JES-33669-79993 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-13
Dose 1 — Pfizer-BioNTech
2021-01-14
Registered in v-safe
2021-01-14
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-15
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain, Swelling, Itching · Muscle or body aches

Adult check-in
2021-01-17
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fever · Chills

Adult check-in
2021-01-18
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-19
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-23
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-27
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-02-03
Dose 2 — Pfizer-BioNTech
2021-02-24
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-03-05
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-10
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-17
Health check-in — day 42, dose 2
Feeling: Fair

Adult check-in
2021-05-05
Survey response — 3 months, dose 2
MedDRA: Ascites, Failed in vitro fertilisation, Sinusitis, Upper respiratory tract infection — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: Ascites. Failed embryo transfer. Sinus and Upper Respiratory Tract Infection.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-05
Report sent to call center — 3 months, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-08-04
Survey response — 6 months, dose 2
MedDRA: Hyperemesis gravidarum, Pregnancy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Pregnancy with hyperemesis graviderum

MedDRA releases: 2021-09,2024-11 · check-in free text available
2022-01-05
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-13	Pfizer-BioNTech
2	2021-02-03	Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 8 — 3 months, dose 2

2021-05-05

Symptoms: Ascites. Failed embryo transfer. Sinus and Upper Respiratory Tract Infection.

Release 9 — 6 months, dose 2

2021-08-04

Symptoms: Pregnancy with hyperemesis graviderum

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Ascites	✓	✓	✓
SD	Failed in vitro fertilisation	✓	✓	✓
SD	Hyperemesis gravidarum	✓	·	✓
SD	Pregnancy	✓	·	✓
SD	Sinusitis	✓	✓	✓
SD	Upper respiratory tract infection	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release